Skip to content

Breakthrough Therapies for Skin Diseases™

Enrollment Complete in Phase 2 Trial of Topical Therapy for Molluscum Contagiosum

Alphyn
Breakthrough Therapies for Skin Diseases
Alphyn
  • About
    • What We Do
    • Leadership & Board
    • Science Advisory
  • Platform
    • Zabalafin Platform
  • Pipeline
    • Atopic Dermatitis
  • Research
    • Clinical Presentations
    • Scientific Papers
  • News
    • Press Releases
    • In the News
    • Events
  • Contact Us
  • About
    • What We Do
    • Leadership & Board
    • Science Advisory
  • Platform
    • Zabalafin Platform
  • Pipeline
    • Atopic Dermatitis
  • Research
    • Clinical Presentations
    • Scientific Papers
  • News
    • Press Releases
    • In the News
    • Events
  • Contact Us

Daily Archives: March 31, 2025

You are here:
  1. Home
  2. 2025
  3. March
  4. 31

Dermatology Times: Q1 Dermatology Drug & Device Report: FDA Approvals & Pipeline Updates

NewsBy adminMarch 31, 2025

Dermatology Times: Q1 Dermatology Drug & Device Report: FDA Approvals & Pipeline Updates by Emma Andrus NEWS PROVIDED BY Alphyn Biologics March 31, 2025 Exclusive Q1 Report: A comprehensive look at the latest FDA approvals and pipeline developments in dermatology from the first quarter of 2025. Read the Dermatology Times article here. CONTACTS   Corporate: Neal…

Copyright 2026, Alphyn Biologics, Inc. All rights reserved. | Website Design by ABWeb Beacon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to Top